Literature DB >> 19105889

Influence of a single oral dose of vitamin D(2) on serum 25-hydroxyvitamin D concentrations in tuberculosis patients.

A R Martineau1, A M Nanzer, K R Satkunam, G E Packe, S J Rainbow, Z J Maunsell, P M Timms, T R Venton, S M Eldridge, R N Davidson, R J Wilkinson, C J Griffiths.   

Abstract

SETTING: Newham Chest Clinic, London, UK.
OBJECTIVE: To determine the safety and efficacy of the administration of bolus-dose vitamin D(2) in elevating serum 25-hydroxyvitamin D (25[OH]D) concentrations in tuberculosis (TB) patients.
DESIGN: A multi-ethnic cohort of TB patients was randomised to receive a single oral dose of 2.5 mg vitamin D(2) (n = 11) or placebo (n = 14). Serum 25(OH)D and corrected calcium concentrations were determined at baseline and 1 week and 8 weeks post-dose, and compared to those of a multi-ethnic cohort of 56 healthy adults receiving an identical dose of vitamin D(2).
RESULTS: Hypovitaminosis D (serum 25[OH]D < 75 nmol/l) was present in all patients at baseline. A single oral dose of 2.5 mg vitamin D2 corrected hypovitaminosis D in all patients in the intervention arm of the study at 1 week post-dose, and induced a 109.5 nmol/l mean increase in their serum 25(OH)D concentration. Hypovitaminosis D recurred in 10/11 patients at 8 weeks post-dose. No patient receiving vitamin D(2) experienced hypercalcaemia. Patients receiving 2.5 mg vitamin D(2) experienced a greater mean increase in serum 25(OH)D at 1 week post-dose than healthy adults receiving 2.5 mg vitamin D(2).
CONCLUSION: A single oral dose of 2.5 mg vitamin D(2) corrects hypovitaminosis D at 1 week but not at 8 weeks post-dose in TB patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19105889

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  14 in total

Review 1.  Nutritional supplements for people being treated for active tuberculosis.

Authors:  Liesl Grobler; Sukrti Nagpal; Thambu D Sudarsanam; David Sinclair
Journal:  Cochrane Database Syst Rev       Date:  2016-06-29

2.  Proceedings of the Rank Forum on Vitamin D.

Authors:  S A Lanham-New; J L Buttriss; L M Miles; M Ashwell; J L Berry; B J Boucher; K D Cashman; C Cooper; A L Darling; R M Francis; W D Fraser; C P G M de Groot; E Hyppönen; M Kiely; C Lamberg-Allardt; H M Macdonald; A R Martineau; T Masud; A Mavroeidi; C Nowson; A Prentice; E M Stone; S Reddy; R Vieth; C M Williams
Journal:  Br J Nutr       Date:  2010-12-07       Impact factor: 3.718

Review 3.  The Echo of Pulmonary Tuberculosis: Mechanisms of Clinical Symptoms and Other Disease-Induced Systemic Complications.

Authors:  Laneke Luies; Ilse du Preez
Journal:  Clin Microbiol Rev       Date:  2020-07-01       Impact factor: 26.132

Review 4.  The vitamin D-antimicrobial peptide pathway and its role in protection against infection.

Authors:  Adrian F Gombart
Journal:  Future Microbiol       Date:  2009-11       Impact factor: 3.165

Review 5.  Large, single-dose, oral vitamin D supplementation in adult populations: a systematic review.

Authors:  Malcolm D Kearns; Jessica A Alvarez; Vin Tangpricha
Journal:  Endocr Pract       Date:  2014-04       Impact factor: 3.443

6.  Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa.

Authors:  Adrian R Martineau; Shepherd Nhamoyebonde; Tolu Oni; Molebogeng X Rangaka; Suzaan Marais; Nonzwakazi Bangani; Relebohile Tsekela; Lizl Bashe; Virginia de Azevedo; Judy Caldwell; Timothy R Venton; Peter M Timms; Katalin A Wilkinson; Robert J Wilkinson
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-24       Impact factor: 11.205

7.  High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial.

Authors:  Adrian R Martineau; Peter M Timms; Graham H Bothamley; Yasmeen Hanifa; Kamrul Islam; Alleyna P Claxton; Geoffrey E Packe; John C Moore-Gillon; Mathina Darmalingam; Robert N Davidson; Heather J Milburn; Lucy V Baker; Richard D Barker; Nicholas J Woodward; Timothy R Venton; Korina E Barnes; Christopher J Mullett; Anna K Coussens; Clare M Rutterford; Charles A Mein; Geraint R Davies; Robert J Wilkinson; Vladyslav Nikolayevskyy; Francis A Drobniewski; Sandra M Eldridge; Christopher J Griffiths
Journal:  Lancet       Date:  2011-01-05       Impact factor: 79.321

8.  L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial.

Authors:  Anna P Ralph; Govert Waramori; Gysje J Pontororing; Enny Kenangalem; Andri Wiguna; Emiliana Tjitra; Dina B Lolong; Tsin W Yeo; Mark D Chatfield; Retno K Soemanto; Ivan Bastian; Richard Lumb; Graeme P Maguire; John Eisman; Ric N Price; Peter S Morris; Paul M Kelly; Nicholas M Anstey
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

9.  Appropriate vitamin D loading regimen for patients with advanced lung cancer.

Authors:  L John Hoffer; Line Robitaille; Nelda Swinton; Jason Agulnik; Victor Cohen; David Small; Carmela Pepe; Shaun Eintracht
Journal:  Nutr J       Date:  2016-10-06       Impact factor: 3.271

10.  Vitamin D Deficiency and Air Pollution Exacerbate COVID-19 Through Suppression of Antiviral Peptide LL37.

Authors:  Mardi A Crane-Godreau; Kathleen J Clem; Peter Payne; Steven Fiering
Journal:  Front Public Health       Date:  2020-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.